Ledger.Open graph →
SEC Form D · filed October 11, 2013

GLYCOS BIOTECHNOLOGIES INC

Offering
$1.5M
Sold
$375K
Exemption
Rule 506(b)
Industry
Other Technology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Dan Watkins · Houston, TXDirectorRichard C. Cilento · Houston, TXExec · DirectorDavid Toth · Ivins, UTExec · DirectorRandi Schochet · Fort Lee, NJDirectorWalter S. Burnap · Houston, TXExec · DirectorMichaline Todd · San Carlos, CADirectorGary Mossman · Houston, TXDirectorDick Costolo · Wilmette, ILExec · DirectorAdam Goller · Fort Lee, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗